Cargando…
A Holistic View of the Goto-Kakizaki Rat Immune System: Decreased Circulating Immune Markers in Non- Obese Type 2 Diabetes
Type-2 diabetes is a complex disorder that is now considered to have an immune component, with functional impairments in many immune cell types. Type-2 diabetes is often accompanied by comorbid obesity, which is associated with low grade inflammation. However,the immune status in Type-2 diabetes ind...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9168276/ https://www.ncbi.nlm.nih.gov/pubmed/35677049 http://dx.doi.org/10.3389/fimmu.2022.896179 |
_version_ | 1784720969003171840 |
---|---|
author | Seal, Snehaa V. Henry, Mathilde Pajot, Clémentine Holuka, Cyrielle Bailbé, Danielle Movassat, Jamileh Darnaudéry, Muriel Turner, Jonathan D. |
author_facet | Seal, Snehaa V. Henry, Mathilde Pajot, Clémentine Holuka, Cyrielle Bailbé, Danielle Movassat, Jamileh Darnaudéry, Muriel Turner, Jonathan D. |
author_sort | Seal, Snehaa V. |
collection | PubMed |
description | Type-2 diabetes is a complex disorder that is now considered to have an immune component, with functional impairments in many immune cell types. Type-2 diabetes is often accompanied by comorbid obesity, which is associated with low grade inflammation. However,the immune status in Type-2 diabetes independent of obesity remains unclear. Goto-Kakizaki rats are a non-obese Type-2 diabetes model. The limited evidence available suggests that Goto-Kakizaki rats have a pro-inflammatory immune profile in pancreatic islets. Here we present a detailed overview of the adult Goto-Kakizaki rat immune system. Three converging lines of evidence: fewer pro-inflammatory cells, lower levels of circulating pro-inflammatory cytokines, and a clear downregulation of pro-inflammatory signalling in liver, muscle and adipose tissues indicate a limited pro-inflammatory baseline immune profile outside the pancreas. As Type-2 diabetes is frequently associated with obesity and adipocyte-released inflammatory mediators, the pro-inflammatory milieu seems not due to Type-2 diabetes per se; although this overall reduction of immune markers suggests marked immune dysfunction in Goto-Kakizaki rats. |
format | Online Article Text |
id | pubmed-9168276 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-91682762022-06-07 A Holistic View of the Goto-Kakizaki Rat Immune System: Decreased Circulating Immune Markers in Non- Obese Type 2 Diabetes Seal, Snehaa V. Henry, Mathilde Pajot, Clémentine Holuka, Cyrielle Bailbé, Danielle Movassat, Jamileh Darnaudéry, Muriel Turner, Jonathan D. Front Immunol Immunology Type-2 diabetes is a complex disorder that is now considered to have an immune component, with functional impairments in many immune cell types. Type-2 diabetes is often accompanied by comorbid obesity, which is associated with low grade inflammation. However,the immune status in Type-2 diabetes independent of obesity remains unclear. Goto-Kakizaki rats are a non-obese Type-2 diabetes model. The limited evidence available suggests that Goto-Kakizaki rats have a pro-inflammatory immune profile in pancreatic islets. Here we present a detailed overview of the adult Goto-Kakizaki rat immune system. Three converging lines of evidence: fewer pro-inflammatory cells, lower levels of circulating pro-inflammatory cytokines, and a clear downregulation of pro-inflammatory signalling in liver, muscle and adipose tissues indicate a limited pro-inflammatory baseline immune profile outside the pancreas. As Type-2 diabetes is frequently associated with obesity and adipocyte-released inflammatory mediators, the pro-inflammatory milieu seems not due to Type-2 diabetes per se; although this overall reduction of immune markers suggests marked immune dysfunction in Goto-Kakizaki rats. Frontiers Media S.A. 2022-05-23 /pmc/articles/PMC9168276/ /pubmed/35677049 http://dx.doi.org/10.3389/fimmu.2022.896179 Text en Copyright © 2022 Seal, Henry, Pajot, Holuka, Bailbé, Movassat, Darnaudéry and Turner https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Immunology Seal, Snehaa V. Henry, Mathilde Pajot, Clémentine Holuka, Cyrielle Bailbé, Danielle Movassat, Jamileh Darnaudéry, Muriel Turner, Jonathan D. A Holistic View of the Goto-Kakizaki Rat Immune System: Decreased Circulating Immune Markers in Non- Obese Type 2 Diabetes |
title | A Holistic View of the Goto-Kakizaki Rat Immune System: Decreased Circulating Immune Markers in Non- Obese Type 2 Diabetes |
title_full | A Holistic View of the Goto-Kakizaki Rat Immune System: Decreased Circulating Immune Markers in Non- Obese Type 2 Diabetes |
title_fullStr | A Holistic View of the Goto-Kakizaki Rat Immune System: Decreased Circulating Immune Markers in Non- Obese Type 2 Diabetes |
title_full_unstemmed | A Holistic View of the Goto-Kakizaki Rat Immune System: Decreased Circulating Immune Markers in Non- Obese Type 2 Diabetes |
title_short | A Holistic View of the Goto-Kakizaki Rat Immune System: Decreased Circulating Immune Markers in Non- Obese Type 2 Diabetes |
title_sort | holistic view of the goto-kakizaki rat immune system: decreased circulating immune markers in non- obese type 2 diabetes |
topic | Immunology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9168276/ https://www.ncbi.nlm.nih.gov/pubmed/35677049 http://dx.doi.org/10.3389/fimmu.2022.896179 |
work_keys_str_mv | AT sealsnehaav aholisticviewofthegotokakizakiratimmunesystemdecreasedcirculatingimmunemarkersinnonobesetype2diabetes AT henrymathilde aholisticviewofthegotokakizakiratimmunesystemdecreasedcirculatingimmunemarkersinnonobesetype2diabetes AT pajotclementine aholisticviewofthegotokakizakiratimmunesystemdecreasedcirculatingimmunemarkersinnonobesetype2diabetes AT holukacyrielle aholisticviewofthegotokakizakiratimmunesystemdecreasedcirculatingimmunemarkersinnonobesetype2diabetes AT bailbedanielle aholisticviewofthegotokakizakiratimmunesystemdecreasedcirculatingimmunemarkersinnonobesetype2diabetes AT movassatjamileh aholisticviewofthegotokakizakiratimmunesystemdecreasedcirculatingimmunemarkersinnonobesetype2diabetes AT darnauderymuriel aholisticviewofthegotokakizakiratimmunesystemdecreasedcirculatingimmunemarkersinnonobesetype2diabetes AT turnerjonathand aholisticviewofthegotokakizakiratimmunesystemdecreasedcirculatingimmunemarkersinnonobesetype2diabetes AT sealsnehaav holisticviewofthegotokakizakiratimmunesystemdecreasedcirculatingimmunemarkersinnonobesetype2diabetes AT henrymathilde holisticviewofthegotokakizakiratimmunesystemdecreasedcirculatingimmunemarkersinnonobesetype2diabetes AT pajotclementine holisticviewofthegotokakizakiratimmunesystemdecreasedcirculatingimmunemarkersinnonobesetype2diabetes AT holukacyrielle holisticviewofthegotokakizakiratimmunesystemdecreasedcirculatingimmunemarkersinnonobesetype2diabetes AT bailbedanielle holisticviewofthegotokakizakiratimmunesystemdecreasedcirculatingimmunemarkersinnonobesetype2diabetes AT movassatjamileh holisticviewofthegotokakizakiratimmunesystemdecreasedcirculatingimmunemarkersinnonobesetype2diabetes AT darnauderymuriel holisticviewofthegotokakizakiratimmunesystemdecreasedcirculatingimmunemarkersinnonobesetype2diabetes AT turnerjonathand holisticviewofthegotokakizakiratimmunesystemdecreasedcirculatingimmunemarkersinnonobesetype2diabetes |